Diabetes is a common and serious disease leading to chronic, mostly irreversible macro and microvascular complications. Microvascular complications include retinopathy, neuropathy, and nephropathy. Macrovascular complications include cardiovascular, cerebrovascular, and peripheral vascular disease. 1 Coronary artery disease (CAD) is one of the macrovascular complication accounting for as many as 80% of death in diabetic patients, furthermore the prevalence of silent myocardial ischemia among individuals with DM is high ranging from 20% to >50%. 2 Myocardial ischemia is defined as a transient and reversible decrease in oxygen to myocardium, leading to an inadequacy of contribution/ need ratio. It is responsible for the following sequential events: initially haemodynamic changes followed by kinetic changes (elevated end diastolic left ventricular pressure), metabolic (lactate production), electrical (repolarisation change) and clinical 
Silent myocardial ischemia is particularly concerned in diabetic patients. It is suspected that partial or complete autonomic denervation in diabetic causes impaired symptom perception e.g. lack of recognition of chest pain leading to SMI. 4 Silent myocardial ischemia (SMI) can be detected by using cardiac stress testing. SMI has been defined as exercise induced ST depression of >1mm in the absence of CAD symptoms 5 . Patients with a resting ECG suggestive of ischemia or infarction should undergo stress testing independent of previous or ongoing symptoms. In addition, asymptomatic patients with diabetes and two or more cardiovascular risk factors should also undergo stress testing. These risk factors include: total cholesterol >240mg/dl, LDL>160mg/dl, HDL<35mg/dl, BP>140/90mm Hg, smoking, family history of premature CAD and microalbuminuria or proteinuria. 4 Microalbminuria in type 2 DM reflects an underlying predisposition to developing progressive kidney diseases as well as serving as a marker of predilection for generalized cardiovascular disease. 6 Persistent microalbuminuria has also been associated with an increase risk of atherosclerosis and cardiovascular mortality. Therefore, patients with diabetes should be screened regularly for microalbuminuria. 7 Silent myocardial ischemia leading to development of future CAD is common in Type 2 DM but more common in Type 2 DM with microalbuminuria. Therefore, microalbuminuria can be used as an early marker as well as for risk stratification of cardiovascular disease. 8 Microalbuminuria is defined as low level of urinary albumin excretion of 30 to 300 mg/day or 20-200 µg/min in which it gives the urinary concentration of albumin 20-200mg/dl. 9, 11 The possible pathophysiologic link between microalbuminuria and atherosclerosis is the increased generalized transvascular leakage of albumin. It is hypothesized that the systemic transvascular leakiness may also include lipoproteins, thus allowing for increased lipid penetration into the vessel wall. The leakiness might be due to hemodynamic factors or structural or functional perturbations of the endothelium or the intracellular matrix beneath. 10 Coronary artery disease (CAD) is the most common form of heart disease and the single most important cause of premature death in all regions of the world. Since the silent myocardial ischemia (SMI) is more common in diabetic population therefore identification of SMI in many asymptomatic type 2 diabetic patients are important for the prevention of future myocardial infarction.
SMI is diagnosed by conventional cardiac stress testing. Presence of SMI can also be suspected by microalbuminuria (MAU) because recently it is claimed that as an early marker microalbumin, may be a useful indicator for early detection of SMI particularly for screening purpose.
Methods:
It was a cross sectional study carried out in the Department of Biochemistry, BSMMU during the period of July 2006 to June 2008. Diagnosed type 2 DM patients were selected from out patient department of BIRDEM.
Enrolled study subjects were advised to do ETT and fifty subjects were selected randomly as ETT +ve (with silent myocardial ischemia) & fifty as ETT -ve (without silent myocardial ischemia) on the basis of ETT findings. Exercise ECG (ECG during ETT) was performed by using 12 standard leads on a treadmill according to Bruce protocol. The protocol had seven stages, each lasting 3 min resulting in 21 minute exercise for a complete test 12 .
The exercise test was considered positive if there was a horizontal and down slopping ST segment depression of at least 1 mm occurring at least 0.08s after the J point. The test was considered negative when the heart reached the maximal predicted exercise heart rate (calculated without a change in ST segment with the ASTRAND formula, 220-age) without a change in ST segment 12 .
For micro albumin desired amount of urine was collected from ETT +ve & ETT-ve patients. Urinary micro albumin concentration was measured by immunometric assay 9 . Microalbuminuria is defined as urinary albumin excretion of 30 to 300 mg/day or 20-200 µg/min.Chi square test, unpaired t test and odds ratio were used to see the level of significance. Table I shows grouping of the study subjects with age & sex distribution. Unpaired t test & Chi square test done but no significant differences found between two groups with respect to age & sex. (Table II) . 
Results:

